HYPERTROPHIC CARDIOMYOPATHY. 2ND EDITION

HYPERTROPHIC CARDIOMYOPATHY. 2ND EDITION

Editorial:
SPRINGER
Año de edición:
Materia
Cardiología
ISBN:
978-3-319-92422-9
Páginas:
479
N. de edición:
2
Idioma:
Inglés
Ilustraciones:
213
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

187,20 €

Despues:

177,84 €

1. Hypertrophic Cardiomyopathy: The Past, the Present, and the Future
2. Natural History of Hypertrophic Cardiomyopathy
3. Pathology and Pathophysiology
4. Approach to Diagnosis: Echocardiography
5. Cardiac MRI in Diagnosis and Management
6. Genetics of HCM and Role of Genetic Testing
7. Assessment of Heart Failure: Invasive and Noninvasive Methods
8. Assessment of Syncope
9. Pediatric Diagnosis and Management
10. Sudden Cardiac Death Risk Assessment
11. Youth and Athletic Screening: Rationale, Methods, and Outcome
12. Lifestyle Modification: Diet, Exercise, Sports, and Other Issues
13. Diet, Nutrition, and Managing Obesity
14. Family Screening: Who, When, and How
15. Medical Therapy: From Beta-Blockers to Disopyramide
16. Hypertension and Hypertrophic Cardiomyopathy
17. Diagnosing and Managing Pulmonary and Right-Sided Heart Disease: Pulmonary Hypertension, Right Ventricular Outflow Pathology, and Sleep Apnea
18. Epiphenomena in Hypertrophic Cardiomyopathy: Acquired von Willebrand Syndrome
19. Epicardial and Microvascular Ischemia: Implications, Diagnosis, and Management
20. Indications and Outcome of PPM and ICD Placement
21. Management of Arrhythmia: Medications, Electrophysiology Studies, and Ablation
22. Indications for and Individualization of Septal Reduction Therapy
23. Surgical Myectomy and Associated Procedures: Techniques and Outcomes
24. Alcohol Septal Ablation: Technique and Outcome
25. Managing the High-Risk Patient: Critical Care, TAVR, MitraClip, Pressors, and Cardiac Assist Devices
26. End-Stage Diastolic and Systolic Heart Failure: Evaluation and Timing of Heart Transplantation
27. Novel Medical Therapeutics for Hypertrophic Cardiomyopathy
28. Approach to the Initial and Follow-Up Visits
29. Evaluation and Management of Hypertrophic Cardiomyopathic Patients Through Noncardiac Surgery and Pregnancy
30. Building a Hypertrophic Cardiomyopathy Center of Excellence
31. Longitudinal Case-Based Presentations in HCM

This extensively updated edition provides a comprehensive review of hypertrophic cardiomyopathy, the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level. The disease produces abnormal and oftentimes focal hypertrophy on a macroscopic level that further impairs cardiac performance and may lead to life-threatening arrhythmias. This edition provides a practical approach, establishing evidence-based best practice for all scenarios.
Hypertrophic Cardiomyopathy provides readers with key points and critical clinical pearls to assist them in managing patients. New chapters have been included on managing hypertension, sleep apnea, coronary artery disease, structural and congenital disease, nutrition and pharmacotherapies. All aspects of treatment are covered – medications, pacemakers and defibrillators, and invasive septal reduction therapy (both surgical myectomy and alcohol septal ablation) – in addition to genetics, family screening, lifestyle concerns, and athletic screening. The practical approach has been reinforced with an expanded emphasis on creating a Center of Excellence, how to facilitate the multi-disciplinary approach, and on case-based reviews and discussions, with each chapter ending with a post-test.
This book is an essential text for cardiology professionals from trainee to board-certified physician, and includes important information for interventional cardiologists, cardiac surgeons, cardiac imagers, critical care physicians, sports medicine physicians, genetic counsellors, and electrophysiologists.

Features
• Represents an up-to-date and comprehensive reference written by experts in the field of this increasingly important area in cardiology
• Concentrates on the multi-disciplinary and longitudinal nature of the disease and provides evidence-based solutions for management where available
• Contains clinical pearls to help the reader understand the nuances of this disease that have not previously been disseminated to the wider community
• Promotes practical understanding of the management of this disease through board-style questions and answers on each topic

Author
Srihari S. Naidu MD, FSCAI, FACC, FAHA, Editor of Hypertrophic Cardiomyopathy is an Associate Professor of Medicine at New York Medical College, and Director of the Hypertrophic Cardiomyopathy Center and Cardiac Catheterization Laboratories at Westchester Medical Center in Valhalla, New York. He completed training in internal medicine at New York Presbyterian Hospital - Cornell Medical Center and general and interventional cardiology at the University of Pennsylvania Medical Center.
A recognized expert in the management of patients with Hypertrophic Cardiomyopathy in general, and the minimally-invasive alternative to open heart surgery alcohol septal ablation in particular, Dr. Naidu runs a comprehensive, multi-disciplinary Hypertrophic Cardiomyopathy Center of Excellence and has managed over 1000 patients with the disease. The author of over 100 original manuscripts, Dr. Naidu lectures regularly throughout the United States on Hypertrophic Cardiomyopathy, Interventional Cardiology, and leadership aspects to achieving career success, and co-runs a live national proctoring course on the alcohol septal ablation technique.
A nationally regarded cardiologist, Dr. Naidu serves on several committees within the American College of Cardiology (ACC), has co-authored or chaired national guidelines and consensus statements, and is a Former Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI). For SCAI, he founded the Emerging Leader Mentorship (ELM) Program, an executive leadership track for promising physicians. A graduate of Brown University for both college and medical school, Dr. Naidu is Past President of the Brown Medical School Board of Directors and current Trustee of the Brown University Corporation.